Ono Pharma has offered $25.60 per share in cash, a premium of 74.7 per cent to U.S.-based Deciphera's last closing price of $14.65 while some shareholders who own about 28% of Deciphera's outstanding stock have already agreed to tender their shares and support the deal, which is expected to close in the third quarter of 2024,
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ohnM0bZ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment